scispace - formally typeset
B

Bruno A. Marichal-Cancino

Researcher at Autonomous University of Aguascalientes

Publications -  41
Citations -  609

Bruno A. Marichal-Cancino is an academic researcher from Autonomous University of Aguascalientes. The author has contributed to research in topics: Cannabinoid receptor & Stimulation. The author has an hindex of 12, co-authored 37 publications receiving 407 citations. Previous affiliations of Bruno A. Marichal-Cancino include CINVESTAV & National Autonomous University of Mexico.

Papers
More filters
Journal ArticleDOI

Advances in the Physiology of GPR55 in the Central Nervous System.

TL;DR: GPR55 mRNA is expressed in several brain areas as the hippocampus, hypothalamus, frontal cortex and cerebellum; but due to the lack of information, only some speculative information about its function in these regions has been suggested.
Journal ArticleDOI

Side effects associated with current and prospective antimigraine pharmacotherapies

TL;DR: This review considers the adverse (or potential) side effects produced by current and prospective antimigraine drugs, including medication overuse headache (MOH) produced by ergots and triptans, the side effects observed in clinical trials for the new gepants and CGRP antibodies, and a section discussing the potential effects resulting from disruption of the cardiovascular CGRPergic neurotransmission.
Journal ArticleDOI

Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia.

TL;DR: In this article, the role of diabetes in the development of some bacterial and viral infections by analyzing preclinical and clinical findings is discussed, and the possible mechanisms by which hyperglycemia may increase the susceptibility for developing infections.
Journal ArticleDOI

Antimicrobial and antibiofilm activity of biopolymer-Ni, Zn nanoparticle biocomposites synthesized using R. mucilaginosa UANL-001L exopolysaccharide as a capping agent

TL;DR: The exopolysaccharide produced by Rhodotorula mucilaginosa UANL-001L is an excellent candidate as a capping agent in the synthesis of biopolymer-metal nanoparticle biocomposites, which demonstrate to be potential contenders as novel antimicrobial agents against both Gram-negative and Gram-positive clinically relevant resistant bacterial strains.